Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy. Casodex Combination Study Group (Q40944828)
Jump to navigation
Jump to search
scientific article published on January 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy. Casodex Combination Study Group |
scientific article published on January 1996 |
Statements
1 reference
Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy. Casodex Combination Study Group (English)
1 reference
Schellhammer P
1 reference
Sharifi R
1 reference
Block N
1 reference
Soloway M
1 reference
Venner P
1 reference
Patterson AL
1 reference
Sarosdy M
1 reference
Vogelzang N
1 reference
Jones J
1 reference
Kolvenbag G
1 reference
1 January 1996
1 reference
1 reference
47
1 reference
1A Suppl
1 reference
54-60; discussion 80-4
1 reference
Identifiers
1 reference
1 reference